Kidney Cancer And The Risk For Chronic Kidney Disease: Matched-Paired Comparison With Living Donors
Found on 09 Jun 2008 08:10 GMT
ORLANDO, FL (UroToday.com) - Dr Koenig from the Cleveland Clinic presented some important data regarding the risk of chronic renal disease in patients diagnosed with kidney cancer. Living kidney donors tolerate nephrectomy without long-term sequelae and this is often extrapolated to patients with renal tumors.
Kidney Cancer
Kidney cancer Definition Kidney cancer is a disease in which the cells in certain tissues of the kidney start to grow uncontrollably and form tumors. Renal cell carcinoma , sometimes referred to as hypernephroma, occurs in the cells lining the kidneys (epithelial cells). It is the most common type
Major League Baseball Hall of Famer Don Sutton Helps Kidney Cancer Patients Stay In The Game.
- Program Empowers and Educates Kidney Cancer Community to Effectively Manage Disease - NEW YORK, May 5 /PRNewswire-FirstCall/ - In response to the increasing incidence of kidney cancer in the United States,(1) Major League Baseball (MLB) Hall-of-Fame pitcher and advanced kidney cancer survivor,
Upsurge of kidney cancer in women linked to obesity Doctors alarmed as incidence of disease soars 22 per cent in 10 years
CANCER SPECIALISTS are blaming rising levels of obesity for an alarming increase in the incidence of kidney cancer among women in Britain. According to statistics from the charity Cancer Research UK, the incidence of the disease in women has jumped 22 per cent over the past 10 years - higher than
The Kidney Cancer Association Supports New Medicare Reimbursement Code For High-Dose Interleukin-2 for Metastatic Kidney Cancer.
EVANSTON, Ill., Sept. 29 /PRNewswire/ - The Kidney Cancer Association applauds the federal Centers for Medicare and Medicaid Services (CMS) for their recent decision to implement a change in the Medicare reimbursement code for high-dose interleukin-2 (IL-2). Patients all across the United States
Olympian Mark Spitz Teams up with Antigenics, NASDAQ and the Kidney Cancer Association to Raise Kidney Cancer Awareness.
Business Editors/Health/Medical Writers BIOWIRE2K NEW YORKBUSINESS WIREMarch 23, 2004 Market Open Ceremony to Recognize National Kidney Month Antigenics Inc. (NASDAQ: AGEN) today announced that Olympic swimming legend Mark Spitz, whose father has suffered from kidney cancer, and the Kidney Cancer
USC Researchers Suggest Possible Cause for Kidney Cancer; Lipid Peroxidation Might Be Key Mechanism for Mysterious Malignancy.
Byline: University of Southern California LOS ANGELES, May 23 (AScribe Newswire) - When faced with the challenge of treating patients with kidney cancer, doctors know that today's chemotherapy offers little help. But a new study from the Keck School of Medicine of USC identifies a possible origin
NHS in crisis: Kidney cancer cases see a dramatic rise.
Kidney cancer cases have risen by 68 per cent in the past 20 years. The startling rise in the incidence of the disease was disclosed by Cancer Research UK today. More than 5,700 people are now affected in Britain each year and survival rates are among the lowest in Europe, it said. The disease can
Cleveland Clinic Begins Enrolling Patients in Genzyme Molecular Oncology's Kidney Cancer Clinical Trial.
The prestigious Cleveland Clinic is now enrolling patients in a Phase I/II clinical trial in kidney cancer conducted by Genzyme Molecular Oncology . Ronald Bukowski, M.D., of the Cleveland Clinic, is the lead investigator of the trial at this site. Genzyme Molecular Oncology, a division of Genzyme
New drugs, new hope; Medications offer options for kidney cancer puzzle
For more than a decade, patients with advanced kidney cancer have had limited options for treatment of their disease. However, the recent approval of two drugs that either slow or stabilize tumor growth provides new weapons to fight the condition. The drug Sutent, which was approved by the Food and
Bayer to commercialize here its oral drug against advanced kidney cancer.
Byline: MELODY M. AGUIBA Germany-based Bayer has developed an oral anti-cancer drug called Sorafenib for the treatment of patients with advanced kidney cancer which may eventually be commercialized in the Philippines. While there is no definite schedule yet for Sorafenib tablets' distribution in
